Metoclopramide is used for the symptomatic treatment of post-operative or chemotherapy-induced nausea and vomiting, gastroesophageal reflux disease and gastroparesis. Metoclopramide is generally ...

Expert Rev Endocrinol Metab. 2010;5(5):653-662.

Get detailed information on Metoclopramide, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

Courtney Southwick is a freelance writer focusing on health, nutrition, and disease. She has been blogging for the past two ...

Metoclopramide is a central dopamine D2-receptor antagonist used as an antiemetic and gastroprokinetic agent in dogs and cats 1,2,3,4. It has been used experimentally in pigeons as an antiemetic ...

SOLANA BEACH, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company ...

Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing ...

Evoke Pharma (EVOK) shares rocketed 90% on positive data for its nasal drug Gimoti in the treatment of stomach paralysis in ...

It is driven by rising diabetes rates. The global gastroparesis drugs market is set to grow by $1.42b from 2024 to 2028, with ...

Evoke Pharma Inc (NASDAQ: EVOK) opened well over 100% up on Monday after reporting positive results for a study on its ...